GAINESVILLE, FL, Privately-held, clinical stage biotechnology company developing gene therapy products to treat rare retinal diseases, announced today that it has secured $37.5 million in a Series B round of financing. Read More
MONTREAL, CANADA, Company that designs medical software for physical and cognitive rehabilitation, today announced that it has secured seed capital and is relocating the company's headquarters to Seattle, WA. Read More
SAN FRANCISCO, CA, Full-service hardware incubator raised $1.85 million in funding, which will allow existing and future startups within its program to successfully execute upon their road maps. Read More
OTTAWA, CANADA, Espresso Capital Partners (ECP) recently led a $1.1 million round of financing in Ottawa-based Sidense, a leading developer of silicon-proven embedded non-volatile memory (NVM) intellectual property. Read More